Zenas BioPharma ZBIO
NASDAQ ZBIO
$28.58 +0.01 (+0.04%)
At close: Nov 10, 2026 · 4:00 PM EST

Zenas BioPharma (ZBIO) Capital Expenditures (2024 - 2026)

Updated

Analysis

Zenas BioPharma (ZBIO) Capital Expenditures (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 1.36 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 301.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 237.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 573.00 Mn
10 Zenas BioPharma 1.84 Bn 1.17 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2,000.00
Mar 31, 2025 18,000.00
Dec 31, 2024 74,000.00
Jun 30, 2024 35,000.00
Mar 31, 2024 22,000.00
API Access

Zenas BioPharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ZBIO&period=max&api_key=YOUR_API_KEY